BuChE-IN-2 is a potent butyrylcholinesterase (BuChE) inhibitor (IC50s of 1.28 μM and 0.67 μM for BuChE and NO, respectively); it inhibits Aβ aggregation, reduces ROS formation, and chelates Cu2+, with suitable blood-brain barrier (BBB) permeability; it can be used in the study of Alzheimer's disease.